Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Springer

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Pediatric Nephrology (Berlin, Germany)|March 21, 1998
Lack of large, homozygous deletions of the nephronophthisis 1 region in Joubert syndrome type B. APN Study Group. Arbeitsgemeinschaft für Pädiatrische NephrologieF Hildebrandt, H G Nothwang, U Vossmerbäumer, et al.
Pediatrics|January 26, 1999
Clinical and genetic risk factors for cystic fibrosis-related liver diseaseM Wilschanski, J Rivlin, S Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibitionS Turajlic, S J Furney, G Stamp, et al.
Cancer Causes & Control : CCC|July 13, 2013
An institutional strategy to increase minority recruitment to therapeutic trialsVictoria V Anwuri, Lannis E Hall, Katherine Mathews, et al.
Pediatrics|January 30, 2013
Management of type 2 diabetes mellitus in children and adolescentsShelley C Springer, Janet Silverstein, Kenneth Copeland, et al.
Pediatrics|January 30, 2013
Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescentsKenneth C Copeland, Janet Silverstein, Kelly R Moore, et al.
Molecular Medicine (Cambridge, Mass.)|October 31, 2000
Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei bruceiL Troeberg, X Chen, T M Flaherty, et al.
Journal of Oncology Practice|October 17, 2013
Coaching intervention as a strategy for minority recruitment to cancer clinical trialsPaula M Fracasso, Sherry A Goodner, Allison N Creekmore, et al.
Cardiovascular Diabetology|January 28, 2023
Deletion of Tbc1d4/As160 abrogates cardiac glucose uptake and increases myocardial damage after ischemia/reperfusionC Binsch, D M Barbosa, G Hansen-Dille, et al.
British Journal of Cancer|September 19, 2002
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumoursR J Francis, S K Sharma, C Springer, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Pediatric Nephrology (Berlin, Germany)|March 21, 1998
Lack of large, homozygous deletions of the nephronophthisis 1 region in Joubert syndrome type B. APN Study Group. Arbeitsgemeinschaft für Pädiatrische NephrologieF Hildebrandt, H G Nothwang, U Vossmerbäumer, et al.
Pediatrics|January 26, 1999
Clinical and genetic risk factors for cystic fibrosis-related liver diseaseM Wilschanski, J Rivlin, S Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibitionS Turajlic, S J Furney, G Stamp, et al.
Cancer Causes & Control : CCC|July 13, 2013
An institutional strategy to increase minority recruitment to therapeutic trialsVictoria V Anwuri, Lannis E Hall, Katherine Mathews, et al.
Pediatrics|January 30, 2013
Management of type 2 diabetes mellitus in children and adolescentsShelley C Springer, Janet Silverstein, Kenneth Copeland, et al.
Pediatrics|January 30, 2013
Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescentsKenneth C Copeland, Janet Silverstein, Kelly R Moore, et al.
Molecular Medicine (Cambridge, Mass.)|October 31, 2000
Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei bruceiL Troeberg, X Chen, T M Flaherty, et al.
Journal of Oncology Practice|October 17, 2013
Coaching intervention as a strategy for minority recruitment to cancer clinical trialsPaula M Fracasso, Sherry A Goodner, Allison N Creekmore, et al.
Cardiovascular Diabetology|January 28, 2023
Deletion of Tbc1d4/As160 abrogates cardiac glucose uptake and increases myocardial damage after ischemia/reperfusionC Binsch, D M Barbosa, G Hansen-Dille, et al.
British Journal of Cancer|September 19, 2002
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumoursR J Francis, S K Sharma, C Springer, et al.
Pageof 13